2,865 hedge funds and large institutions have $105B invested in Pfizer in 2024 Q2 according to their latest regulatory filings, with 213 funds opening new positions, 1,177 increasing their positions, 1,238 reducing their positions, and 172 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding in top 10

Funds holding in top 10:

more funds holding

Funds holding:

less capital invested

Capital invested by funds: $ → $

5% less repeat investments, than reductions

Existing positions increased: 1,177 | Existing positions reduced: 1,238

1.16% less ownership

Funds ownership: 67.1%65.94% (-1.2%)

40% less call options, than puts

Call options by funds: $2.36B | Put options by funds: $3.9B

Holders
2,865
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
33
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$2.36B
Puts
$3.9B
Net Calls
Net Calls Change

Top Buyers

1 +$346M
2 +$334M
3 +$233M
4
Citadel Advisors
Citadel Advisors
Florida
+$217M
5
Norges Bank
Norges Bank
Norway
+$199M
Name Holding Trade Value Shares
Change
Change in
Stake
2651
$127K
2652
$126K
2653
$125K
2654
$125K
2655
$124K
2656
$120K
2657
$119K
2658
$118K
2659
$116K
2660
$116K
2661
$116K
2662
$114K
2663
$113K
2664
$112K
2665
$112K
2666
$112K
2667
$111K
2668
$109K
2669
$109K
2670
$108K
2671
$108K
2672
$106K
2673
$106K
2674
$105K
2675
$105K